Amino acyl-tRNA synthetases (aTyr Pharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAmino acyl-tRNA synthetases (aTyr Pharma)

Drug Alias NamePhe-tRNA SynthetaseTyrosyl-tRNA SynthetasePhysiocrines - aTyr PharmaResected aspartyl-tRNA synthetase - aTyr PharmaTruncated aspartyl-tRNA synthetase - aTyr Pharma +[11]

ClassificationBiologics

Mechanisms of ActionG-protein coupled receptor modulatorsCytokine receptors modulatorsEnzyme replacements +[6]

TargetsCytokine receptorsG-protein coupled receptorHistidyl-tRNA synthetase +[4]

Therapy Area/IndicationsInflammationImmune System DiseasesThrombocytopenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAtyr Pharma

China Registration ClassN/A

Develop Information

Active CompaniesAtyr Pharma

Inactive CompaniesN/A

Active IndicationsInflammationImmune System DiseasesThrombocytopenia

Inactive IndicationsN/A

Other Information

ATC CodeN/A